Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2012 / Cilt: 46 - Sayı: 1

Psoriasis and obesity

Psoriasis ve obezite

Pages
3–6
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, increasing epidemiological evidence suggests strong association between obesity and psoriasis, increase in serum leptin levels is thought to have a major role, and weight loss may have significant impact on response to treatment. (Turk derm 2012; 46: 3-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In recent years, it has been thought that a strong association exists between metabolic syndrome, specifically obesity, and psoriasis.
📊
Key Findings & Data:Serum leptin levels in patients with severe and moderate psoriasis were found to be higher than in normal control groups.
💡
Conclusion & Impact:Overall, increasing epidemiological evidence suggests strong association between obesity and psoriasis, increase in serum leptin levels is thought to have a major role, and weight loss may have significant impact on response to treatment. (Turk derm 2012; 46: 3-6)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

In recent years, it has been thought that a strong association exists between metabolic syndrome, specifically obesity, and psoriasis. Obesity is a multifactorial disease affected by both genetic and environmental factors. Adipokines (e.g. leptin) secreted by the adipose tissue are believed to play a role in the pathogenesis of psoriasis. The main role of leptin is to adjust metabolism by controlling appetite. Serum leptin levels in patients with severe and moderate psoriasis were found to be higher than in normal control groups. In many similar studies, leptin secretion has been found to stimulate keratinocyte proliferation, which is one of the characteristics of psoriasis. Although many studies showed increased prevalence of obesity in psoriasis patients, few others reported development of obesity in psoriasis patients. Additionally, obesity was found to affect treatment responses not only in classical systemic/topical treatment approaches in psoriasis, but also in newer biological treatments. Overall, increasing epidemiological evidence suggests strong association between obesity and psoriasis, increase in serum leptin levels is thought to have a major role, and weight loss may have significant impact on response to treatment. (Turk derm 2012; 46: 3-6)

Özet

Son yıllarda metabolik sendrom ve onun komponentlerinden olan obezite ile psoriasis arasında güçlü bir ilişki olduğu düşünülmektedir. Obezite, genetik ve çevresel faktörlerin etkileşimi sonucu ortaya çıkan klinik bir bulgudur. Yağ dokusundan salgılanan adipokinlerin ve bunlar içerisinde leptinin psoriasis patogenezinde rol aldığı düşünülmektedir. Leptinin temel görevi iştahı kontrol ederek enerji dengesini sağlamaktır. Serum leptin düzeyleri yapılan çalışmalarda şiddetli psoriasisli hastalarda hafif psoriasislilere ve kontrol grubuna göre yüksek bulunmuştur. Leptin salınımının artışı sonucu ortaya çıkan biyolojik olayların psoriasis için karakteristik olan keratinosit proliferasyonunu tetiklediğine dair görüşler vardır. Psoriasis ile obezite arasındaki ilişkiyi inceleyen çok sayıda klinik çalışmada bu ilişki tespit edilmiştir. Ancak bazı çalışmalar obezlerde psoriasis görülme sıklığını yüksek bulurken, sınırlı sayıdaki diğerleri psoriasisli hastalarda obezite geliştiğini tespit etmişlerdir. Bunun yanında obez psoriasisli hastaların klasik topikal ve sistemik tedaviler yanında biyolojik tedavilere verdikleri yanıt konusunda da özellikler bulunmaktadır. Sonuç olarak psoriasis ile obezite arasındaki ilişkinin leptin düzeylerinin artışı ile ortaya çıktığına ve obez psoriasisli hastaların tedavisinde kilo kontrolünün önemine dair deliller giderek artmaktadır. (Türk derm 2012; 46: 3-6)

🔖

Cite This Article

GÖKALP, H., GÜRER, M. A. (2022). Psoriasis and obesity. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 46 - Sayı: 1, 3–6. https://ajindex.com/articles/621960

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Çelik R, Derviş E, Balaban D, Can G: Psoriasisli Hastalarda Metabolik Sendrom Birlikteliği. Türkderm 2010;44:204-8
  2. Gülekon A, Adışen E: Psoriasis ve komorbiditeler. Türkderm 2008;42:23-5
  3. Naldi L: Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:121-8
  4. Hercogova J, Ricceri F, Tripo L, Lotti T, Prignano F: Psoriasis and body mass index. Dermatol Ther 2010;23:152-4
  5. Wolk K, Mallbris L, Larsson P, et al: Excessive Body Weight and Smoking Associates with a High Risk of Onset of Plaque Psoriasis. Acta Derm Venereol 2009;89:492-7
  6. Döner N, Yaşar Ş, Ekmekçi TR: Obezite ile İlişkili Dermatozların Obezlerde ve Aşırı Kilolularda Araştırı lması. Türkderm 2011;45:146-51
  7. Bremmer S, Voorhees A, Hsu S, et al: Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010;63:1058-69
  8. Duarte GV, Follador I, Cavalheiro CM, Silva TS, Oliveira Mde F: Psoriasis and obesity: literature review and recommendations for management. An Bras Dermatol 2010;85:355-60
  9. Cohen AD, Sheif M, Vidavsky L, et al: Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008;216:152-5
  10. Mehta S, Farmer JA: Obesity and inflammation: A new look at an old problem. Curr Atheroscler Rep 2007;9:134-8
  11. Puig L: Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. JEADV 2011;25:1007-11
  12. Furuhashi M, Fucho R, Görgün ZC, et al: Adipocyte/macrophage fatty acid- binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008;118:2640-50
  13. Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W: Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003;88:2714-8
  14. Dandona P, Weinstock R, Thusu K, et al: Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998;83:2907-10
  15. Antuna-Puente B, Feve B, Fellhai S, Bastard JP: Obesity, inflammation and insulin resistance: Which role for adipokines. Therapie 2007;62:285-92
  16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15
  17. Romanova IV, Ramos EJ, Xu Y, et al: Neurobiologic changes in the hypothalamus associated with weight loss a